Tate & Lyle PLC
TATE: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|&# | LOCK|$<jw@ | LOCK|>?j?@W |
Tate & Lyle Earnings: Cost Synergies Ahead of Plan, Shares Rebound Mid-Single-Digits but Remain Cheap
Tate & Lyle reported a 3% revenue decline and a 6% EBITDA decline on a constant-currency and pro forma basis, in line with expectations following its October preclose statement. Shares rose 5% on Nov. 6 as investors welcomed faster-than-expected cost synergy realization.
